• Facebook
  • Twitter
x

RealTime Images

  • Portfolio
  • About
  • Contact
  • Video
  • Blog
  • Archive
Show Navigation
Cart Lightbox Client Area

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
Next
{ 475 images found }
twitterlinkedinfacebook

Loading ()...

  • The Socialite Paris Hilton visited the community of San Gregorio she made a tour to verify the progress of housing in the areas affected by the earthquake on September 19. on November 12, 2018 in Xochimilco Mexico. Paris Hilton visit the most affected areas of Xochimilco by the earthquake on 2017 and made a donation of 330, 000 USD for the reconstruction of houses. 12 Nov 2018 Pictured: The Socialite Paris Hilton visited the community of San Gregorio she made a tour to verify the progress of housing in the areas affected by the earthquake on September 19. on November 12, 2018 in Xochimilco Mexico. Paris Hilton visit the most affected areas of Xochimilco by the earthquake on 2017 and made a donation of 350, 000 USD for the reconstruction of houses. Photo credit: Carlos Tischler / MEGA TheMegaAgency.com +1 888 505 6342
    MEGA307307_008.jpg
  • The Socialite Paris Hilton visited the community of San Gregorio she made a tour to verify the progress of housing in the areas affected by the earthquake on September 19. on November 12, 2018 in Xochimilco Mexico. Paris Hilton visit the most affected areas of Xochimilco by the earthquake on 2017 and made a donation of 330, 000 USD for the reconstruction of houses. 12 Nov 2018 Pictured: The Socialite Paris Hilton visited the community of San Gregorio she made a tour to verify the progress of housing in the areas affected by the earthquake on September 19. on November 12, 2018 in Xochimilco Mexico. Paris Hilton visit the most affected areas of Xochimilco by the earthquake on 2017 and made a donation of 350, 000 USD for the reconstruction of houses. Photo credit: Carlos Tischler / MEGA TheMegaAgency.com +1 888 505 6342
    MEGA307307_022.jpg
  • Jan. 13, 2015 - Canary Wharf, Gherkin, London, England (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1589.jpg
  • Jan. 13, 2015 - The Gherkin reflected in Leadenhall Building, London, England (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1590.jpg
  • Jan. 13, 2015 - Canary Wharf, London, England (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1588.jpg
  • Jan. 13, 2015 - Gherkin, St Andrew Undershaft, London, England (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1398.jpg
  • Jan. 13, 2015 - Canary Wharf, Gherkin, St Andrew Undershaft, London, England (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1397.jpg
  • Jan. 13, 2015 - Canary Wharf, Gherkin, St Andrew Undershaft, London, England (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1396.jpg
  • Jan. 13, 2015 - Canary Wharf, London, England (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1394.jpg
  • Jan. 13, 2015 - Red construction cranes (Credit Image: © Image Source/Image Source/ZUMAPRESS.com)
    20150113_zaa_i19_1391.jpg
  • Businesswoman sitting in meeting (Credit Image: © Image Source/Albert Van Rosendaa/Image Source/ZUMAPRESS.com)
    20130827_baa_i19_044.jpg
  • Dec. 13, 2012 - Caution tape at construction site (Credit Image: © Image Source/ZUMAPRESS.com)
    20121213_baf_i19_5947.jpg
  • June 8, 2017 - New York, NY, United States - Anthony Long, Pew, Charitable, Trust, Milton Haughton, Caribbean, Regional, Fisheries, Mechanism, Dame, Meg Taylor, Secretary-General, Pacific, Island, Forum, Secretariat, Press, briefing, outcome, biodiversity, stability, conservation, agenda, climate, change, environment, ecology, Ocean, water, Sustainable Development Goals, conference, United Nations, UN, Headquarters, New York City, New York, NY, USA (Credit Image: © Albin Lohr-Jones/Pacific Press via ZUMA Wire)
    20170608_zaa_p133_269.jpg
  • June 15, 2018 - Kyiv, Ukraine - Vice Prime Minister - Minister of Regional Development, Construction, Housing and Communal Services of Ukraine Hennadii Zubko attends the presentation of a report of the Organisation for Economic Co-operation and Development (OECD) on the progress of implementation of decentralisation in Ukraine, Kyiv, capital of Ukraine, June 15, 2018. Ukrinform. (Credit Image: © Danil Shamkin/Ukrinform via ZUMA Wire)
    20180615_zaa_u101_003.jpg
  • June 15, 2018 - Kyiv, Ukraine - Head of Cooperation of the EU Delegation to Ukraine Berend de Groot, Ambassador Extraordinary and Plenipotentiary of the Republic of Poland to Ukraine Jan Pieklo, Vice Prime Minister - Minister of Regional Development, Construction, Housing and Communal Services of Ukraine Hennadii Zubko, OECD Deputy Secretary-General Mari Kiviniemi and OECD expert Maria-Varinia Michalun (L to R) attend the presentation of a report of the Organisation for Economic Co-operation and Development (OECD) on the progress of implementation of decentralisation in Ukraine, Kyiv, capital of Ukraine, June 15, 2018. Ukrinform. (Credit Image: © Danil Shamkin/Ukrinform via ZUMA Wire)
    20180615_zaa_u101_001.jpg
  • April 13, 2018 - Kolkata, West Bengal, India - AISA and AIPWA holds poster to protest against the brutal rape at Kathua and Unnao.  All India Students' Association (AISA) and All India Progressive Women's Association (AIPWA) member take part in a rally to protest against recent brutal rape incident at Kathua city of Jammu and Kashmir and Unnao of Utter Pradesh. (Credit Image: © Saikat Paul/Pacific Press via ZUMA Wire)
    20180413_zaa_p133_177.jpg
  • June 17, 2017 - Seattle, Washington, United States - Seattle, Washington: State Senator and mayoral candidate BOB HASEGAWA greets a visitor at the Beacon Hill Block Party.  In the center is Betty Jean Williamson with Beacon Arts, an all volunteer nonprofit organization dedicated to providing opportunities for artists and audiences in the neighborhood. The senator, a longtime labor and social justice activist from the Beacon Hill neighborhood, has represented the 11th Legislative District since January 2013. (Credit Image: © Paul Gordon via ZUMA Wire)
    20170617_zap_g235_001.jpg
  • June 10, 2017 - Seattle, Washington, United States - Seattle, Washington: State Senator and mayoral candidate Bob Hasegawa appears with the Washington Education Association's Julianna Dauble at the Volunteer Park Pride Festival. The senator, a longtime labor and social justice activist from Seattle, has represented the 11th Legislative District since January 2013. (Credit Image: © Paul Gordon via ZUMA Wire)
    20170610_zap_g235_001.jpg
  • June 1, 2017 - Manhattan, New York, United States - After more than a week of protest & controversy, CUNY School of Public Health held graduation ceremonies in Harlem's Apollo Theater with former president of the Arab American Association of New York, Linda Sarsour, giving a rousing keynote speech...In addition to Ms. Sarsour, Mayor Bill de Blasio's wife, Chirlane McCray received an honorary degree for her work in mental health, & NYC Commissioner for Health, Mary Travis Bassett was honored as the Dean's Champion of Public Health award...Outside, along 125th Street, several dozen protesters representing pro & con positions held vigil. (Credit Image: © Andrew Katz/Pacific Press via ZUMA Wire)
    20170601_zaa_p133_299.jpg
  • May 9, 2017 - Seattle, Washington, United States - Seattle, Washington: State Senators BOB HASEGAWA and MARALYN CHASE pose at the Bob Hasegawa for Seattle mayor campaign announcement. At the press conference, the senator announced his candidacy for Mayor of Seattle on the steps of Wells Fargo Center. A longtime labor and social justice activist from Seattle, the senator has represented the 11th Legislative District since January 2013. (Credit Image: © Paul Gordon via ZUMA Wire)
    RTI20170509_zap_g235_031.jpg
  • May 4, 2019 - Seattle, Washington, U.S - Seattle, Washington: Representative PRAMILA JAYAPAL appears at a fireside chat at the Crosscut Festival. Staff reporter MELISSA SANTOS moderated the discussion at Seattle University. The two-day event featured conversations with journalists, politicians, authors and other civic, business and cultural leaders taking on the most important issues of our times. (Credit Image: © Paul Christian Gordon/ZUMA Wire)
    20190504_zap_g235_001.jpg
  • May 3, 2019 - Seattle, Washington, U.S - Seattle, Washington: Author and co-founder of Citizen University ERIC LIU gives a convocation at the Crosscut Festival’s keynote. The two-day event featured conversations with journalists, politicians, authors and other civic, business and cultural leaders taking on the most important issues of our times. (Credit Image: © Paul Christian Gordon/ZUMA Wire)
    20190503_zap_g235_001.jpg
  • July 24, 2017 - Seattle, Washington, United States - Seattle, Washington: State Senator and mayoral candidate BOB HASEGAWA at the Seattle Mariners vs. Boston Red Sox game at Safeco Field. The senator appeared with SHEILA BURRUS, Executive Director of the Filipino Community of Seattle, to throw the first pitch during Filipino Heritage Night. Hasegawa, a longtime labor and social justice activist from the Beacon Hill neighborhood, has represented the 11th Legislative District since January 2013. (Credit Image: © Paul Gordon via ZUMA Wire)
    20170724_zap_g235_001.jpg
  • Certificate awarded to Phillip Bellwood for Outstanding Progress in 2003/2004.
    Chilton Primary School Progress Cert..cate
  • MUMBAI,Dec. 1, 2018  Indian Students Participate in World Aids day Rally in Mumbai, India  Saturday, Dec. 1, 2018.World AIDS Day has been observed today since 1988 to raise awareness of the AIDS pandemic,A UNICEF report released ahead of World AIDS Day 2018 warned that by 2030, around 80 adolescents will be dying of AIDS every day if ''we don't accelerate progress in preventing transmission. (Credit Image: © Stringer/Xinhua via ZUMA Wire)
    20181201_zaf_x99_204.jpg
  • NEW YORK, June 8, 2011  Rwandan President Paul Kagame speaks during the high level meeting on HIV/AIDS at UN headquarters in New York, the United States, June 8, 2011. The UN General Assembly on Wednesday kicked off a three-day high level meeting on HIV/AIDS, which is expected to provide an opportunity to take stock of the progress and challenges of the last 30 years and shape the future of AIDS response. (Credit Image: © Xinhua via ZUMA Wire)
    20110608_zaf_x99_260.jpg
  • November 17, 2018 - Tunis, Tunisia - Secretary-General Noureddine Taboubi with his deputy Samir Echeffi. The Tunisian General Union of Labor (UGTT) organized a large workers' rally Saturday in Mohamed Ali Square in the capital. Taboubi delivered a speech on the progress of the social negotiations and the general situation in the country. (Credit Image: © Chokri Mahjoub/ZUMA Wire)
    20181117_zaf_m107_007.jpg
  • November 17, 2018 - Tunis, Tunisia - The Tunisian General Union of Labor (UGTT) organized a large workers' rally Saturday, November 17, 2018, in Mohamed Ali Square in the capital.in the presence of Secretary-General Noureddine Taboubi who delivered a speech on the progress of the social negotiations and the general situation in the country. (Credit Image: © Chokri Mahjoub/ZUMA Wire)
    20181117_zaf_m107_003.jpg
  • Dwayne Johnson releases a photo on Instagram with the following caption: "Gettin\u2019 stronger - progress thru pain. \n455lbs barbell glute/hip thrusts with 5 second hold at the top with hip circle above knees for greater glute activation. \nThese small gains for me wind up being big gains in the long run considering the multiple injuries over the years I suffered on the football field and in the wrestling ring. \nTore both my quadricep \u0026 adductor tendons off my pelvis.\nFive knee surgeries.\nTorn Achilles\u2019 tendon.\nTriple hernia (emergency) surgery. \nUpper body I\u2019ve been a pretty lucky SOB over the years having had just one total reconstruction surgery done on my shoulder when I shredded everything. \nWaist up, I\u2019m Superman... Waist down, I\u2019m Bionic Man \ud83d\ude09*inserts cheesy joke. \nIf you\u2019re going thru injuries or set backs \u2014 stay focused, listen to your body and let pain be your guide to come back stronger and better. \nRemember any and all progress, physical or mental - will always come thru pain. \n#ProgressThruPain #IronParadise #CauseIFuckingSaidSo \ud83d\ude08\ud83d\udcaa\ud83c\udffe\nBrotha @c.t.ali.fletcher". Photo Credit: Instagram *** No USA Distribution *** For Editorial Use Only *** Not to be Published in Books or Photo Books ***  Please note: Fees charged by the agency are for the agency’s services only, and do not, nor are they intended to, convey to the user any ownership of Copyright or License in the material. The agency does not claim any ownership including but not limited to Copyright or License in the attached material. By publishing this material you expressly agree to indemnify and to hold the agency and its directors, shareholders and employees harmless from any loss, claims, damages, demands, expenses (including legal fees), or any causes of action or allegation against the agency arising out of or connected in any way with publication of the material.
    23816131.jpg
  • April 17, 2018 - Michurinsk, Tambov region, Russia - In the production workshop of JSC ''Michurinsk plant ''Progress' (Credit Image: © Aleksei Sukhorukov via ZUMA Wire)
    20180417_zap_s171_001.jpg
  • PRETORIA, June 10, 2011  Zimbabwean President Robert Mugabe (R) shakes hands with South African President Jacob Zuma in Pretoria, South Africa, June 10, 2011. Progress on a path to elections in Zimbabwe is expected to be discussed when Mugabe met his South African counterpart Jacob Zuma late on Friday, the Times newspaper in Johannesburg reported. (Credit Image: © Xinhua via ZUMA Wire)
    RTI20110611_zaf_x99_047 - Copy.jpg
  • PRETORIA, June 10, 2011  Zimbabwean President Robert Mugabe (L) shakes hands with South African President Jacob Zuma in Pretoria, South Africa, June 10, 2011. Progress on a path to elections in Zimbabwe is expected to be discussed when Mugabe met his South African counterpart Jacob Zuma late on Friday, the Times newspaper in Johannesburg reported. (Credit Image: © Xinhua via ZUMA Wire)
    RTI20110611_zaf_x99_046 - Copy.jpg
  • October 13, 2017 - New York, New York, U.S - Renowned artist STEPHEN WILTSHIRE continues drawing the Empire State Building and New York City from memory at the Empire State Building on October 13, 2017 in New York. Following a 45-minute helicopter ride around Manhattan, Wiltshire will draw a cityscape beginning today through Sunday, October 15, 2017, culminating with a signing ceremony on Monday, October 16, 2017.  Wiltshire famously creates his artwork from memory and will do this piece in residence on the 80th floor of the Empire State Building. The London-based artist’s progress will be visible to Observatory visitors as he draws from 10 a.m. to 5 p.m. daily. (Credit Image: © Bryan Smith via ZUMA Wire)
    RTI20171013_zap_b148_009.jpg
  • October 13, 2017 - New York, New York, U.S - Renowned artist STEPHEN WILTSHIRE continues drawing the Empire State Building and New York City from memory at the Empire State Building on October 13, 2017 in New York. Following a 45-minute helicopter ride around Manhattan, Wiltshire will draw a cityscape beginning today through Sunday, October 15, 2017, culminating with a signing ceremony on Monday, October 16, 2017.  Wiltshire famously creates his artwork from memory and will do this piece in residence on the 80th floor of the Empire State Building. The London-based artist’s progress will be visible to Observatory visitors as he draws from 10 a.m. to 5 p.m. daily. (Credit Image: © Bryan Smith via ZUMA Wire)
    RTI20171013_zap_b148_006.jpg
  • August 27, 2017 - Paris, France - Hindu community celebrate 22nd Ganesh Festival in Paris, France, on 27 August 2017. Lord Ganesh, one of the most popular Hindu deities, is believed to grant progress, prosperity and wisdom. (Credit Image: © Julien Mattia/NurPhoto via ZUMA Press)
    20170827_zaa_n230_293.jpg
  • August 5, 2017 - Amsterdam, Netherland - On August 5th, 2017. Before and during the celebration of The Canal Parade in Amsterdam, an action called ''We Reclaim our Pride'', took place in one of the bridges of Amsterdam. The reason of this action is, that the Pride has become a celebration that involves the participation of certain corporations and political parties that are far removed from this fight for freedom. This action is oranizated by several groups that cannot celebrate the freedom of one group at the expense of the freedom of other groups. Although the LGBTQI+ movement has made significant progress since the Stonewall riots, there is still a lot to gain when it comes to the liberation from hetero/cis-normativity and sexism in the Netherlands. (Credit Image: © Romy Arroyo Fernandez/NurPhoto via ZUMA Press)
    20170805_zaa_n230_027.jpg
  • May 19, 2017 - Roseville, Michigan, U.S. - Roseville, Michigan USA - 19 May 2017 - Forty thousand workers at AT&T Mobility, which provides wireless service to 134 million people, began a three-day strike to protest the lack of progress in contract negotiations. Job security is a key issue: the company wants to outsource jobs or send them overseas. (Credit Image: © Jim West via ZUMA Wire)
    20170519_zaf_w66_001.jpg
  • COLOMBO, Sept. 3, 2016 (Xinhua) -- UN Secretary-General Ban Ki-moon speaks at a press conference in Colombo, Sri Lanka, Sept. 2, 2016. Ban Ki-moon on Friday called for credible process to address issues related to the war in Sri Lanka when he visited the island nation. The UN Chief who was in Sri Lanka for a two-day official visit told journalists in Colombo that Sri Lanka had made ''great progress'' since his last visit in 2009, but the island nation still faced a lot of challenging issues, even seven years after the war. (Xinhua/Gayan Sameera).****Authorized by ytfs* (Credit Image: © Gayan Sameera/Xinhua via ZUMA Wire)
    20160903_zaf_x99_029.jpg
  • COLOMBO, Sept. 3, 2016 (Xinhua) -- UN Secretary-General Ban Ki-moon speaks at a press conference in Colombo, Sri Lanka, Sept. 2, 2016. Ban Ki-moon on Friday called for credible process to address issues related to the war in Sri Lanka when he visited the island nation. The UN Chief who was in Sri Lanka for a two-day official visit told journalists in Colombo that Sri Lanka had made ''great progress'' since his last visit in 2009, but the island nation still faced a lot of challenging issues, even seven years after the war. (Xinhua/Ajith Perera).****Authorized by ytfs* (Credit Image: © Ajith Perera/Xinhua via ZUMA Wire)
    20160903_zaf_x99_027.jpg
  • South Africa - Cape Town - 30 September 2020  - Holstein Dairy cows in Durbanville. Animal health company, Zoetis has launched a genome test, Clarifide Plus, to predict key cow and calf wellness traits in South Africa’s dairy cattle, which will enable farmers to fine tune their management, selection and breeding decisions with confidence. The genome test allows producers to rank animals with the Dairy Wellness Profit Index (DWP$) which is based on traits that affect health, performance and the lifetime profit of cows and calves. DWP$ describes more genetic variation in profitability allowing for faster progress towards greater profitability. Picture: Henk Kruger/African News Agency(ANA)
    Dairy-cows-8322.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_098.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_097.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_096.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_095.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_094.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_093.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_092.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_090.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_089.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_088.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_086.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_084.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_082.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_081.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_080.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_079.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_077.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_076.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_074.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_073.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_071.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_067.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_065.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_064.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_062.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_061.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_060.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_059.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_058.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_056.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_055.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_053.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_052.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_049.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_048.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_047.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_046.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_045.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_044.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_043.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_042.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_041.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_040.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_039.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_038.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_036.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_035.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_034.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_033.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_032.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_028.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_027.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_025.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_022.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_019.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_018.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_015.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_013.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_012.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_011.jpg
Next